Physician profile
Logan Walker
NPI 1114300928
$1,546.16
in general payments reported to CMS, 2019-2025
19 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.90 · 2020: $201 · 2021: $15.14 · 2022: $546 · 2023: $406 · 2024: $231 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732 · Education: $37.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.75 |
| Education | $37.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $344.89 | 2022-2024 | |
| Novo Nordisk INC | $344.20 | 2020-2024 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $170.29 | 2022-2023 | Vraylar |
| Glaxosmithkline, LLC. | $109.05 | 2022-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Abbott Laboratories | $94.93 | 2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals Lp | $88.72 | 2022-2024 | Farxiga, Breztri |
| Genzyme Corporation | $73.53 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.73 | 2019-2025 | Jardiance |
| Allergan, INC. | $39.87 | 2020 | |
| Ironwood Pharmaceuticals, INC | $37.28 | 2020 | |
| Genentech USA, INC. | $36.44 | 2020 | |
| Lilly USA, LLC | $28.32 | 2022-2023 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $21.89 | 2024 | Rexulti |
| Dexcom, INC. | $18.96 | 2023 | Dexcom G6 Transmitter |
| Amgen INC. | $18.95 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $16.06 | 2023 | Nocdurna, Xyosted, Tlando |
| Philips North America LLC | $13.50 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.12 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.